Multifunctional nanotheranostics for near infrared optical imaging-guided treatment of brain tumors

Li Zhang1, Yue Liu1, Haiyan Huang1

  • 1School of Science, Shenzhen Key Laboratory of Flexible Printed Electronics Technology, Harbin Institute of Technology (Shenzhen), Shenzhen 518055, China.

Insights

Near-infrared optical imaging, including fluorescence and photoacoustic imaging, offers advanced diagnostics and real-time therapy guidance for malignant brain tumors. This review details contrast agents and nanotheranostics for multimodal imaging and treatment strategies, highlighting future clinical translation challenges and opportunities.

Area of Science:

  • Biomedical Imaging
  • Nanotechnology
  • Oncology

Background:

  • Malignant brain tumors are aggressive with poor prognoses.
  • Near-infrared (NIR) optical imaging offers noninvasive, high-resolution diagnostics for CNS tumors.
  • NIR imaging modalities like fluorescence imaging (FLI) and photoacoustic imaging (PAI) show promise for brain tumor detection and therapy guidance.

Purpose of the Study:

  • To systematically review state-of-the-art NIR contrast agents (CAs) for brain tumor imaging.
  • To summarize recent advancements in NIR optical imaging-guided therapies.
  • To discuss the clinical translation potential of CAs and nanotheranostics for brain tumors.

Main Methods:

  • Comprehensive literature review of NIR contrast agents for single, dual, and triple-modal brain tumor imaging (FLI, PAI, MRI, CT).
  • Analysis of recent progress in NIR optical imaging-guided therapies, including photothermal therapy (PTT), photodynamic therapy (PDT), chemotherapy, and gene therapy.
  • Discussion of challenges and opportunities for nanotheranostics in clinical translation.

Main Results:

  • NIR CAs are effective for single-modal (FLI, PAI), dual-modal (FLI/PAI, FLI/MRI, PAI/MRI), and triple-modal (MRI/FLI/PAI, MRI/PAI/CT) brain tumor imaging.
  • NIR optical imaging guides diverse therapies including PTT, PDT, chemotherapy, gene therapy, and combinations thereof.
  • Nanotheranostics show potential for integrated diagnosis and therapy.

Conclusions:

  • NIR optical imaging modalities and advanced contrast agents are revolutionizing brain tumor diagnosis and therapy.
  • Multimodal imaging and combination therapies guided by NIR optical techniques offer improved accuracy and efficiency.
  • Further research into nanotheranostics is crucial for overcoming clinical translation barriers in brain tumor treatment.